Pubblicazioni

Asciminib Provides Durable Molecular Responses in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With the T315I Mutation: Updated Efficacy and Safety Data From a Phase I Trial

2022 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Hughes, Timothy P.; Cortes, Jorge E.; Rea, Delphine; Mauro, Michael J.; Hochhaus, Andreas; Kim, Dong-Wook; Sasaki, Koji; Lang, Fabian; Heinrich, Michael C.; Breccia, Massimo; Deininger, Michael; Goh, Yeow-Tee; Janssen, ; Jeroen, J. W. M.; Talpaz, Moshe; le Coutre, Philipp; Kapoor, Shruti; Cacciatore, Silvia; Polydoros, Fotis; Agrawal, Nithya; Mahon, Francois-Xavier

Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Cortes, Jorge E.; Hughes, Timothy P.; Mauro, Michael J.; Hochhaus, Andreas; Rea, Delphine; Goh, Yeow-Tee; Janssen, J. J. W. M.; Heinrich, Michael C.; Talpaz, Moshe; Etienne, Gabriel; Breccia, Massimo; Deininger, Michael; Le Coutre, Philipp; Lang, Fabian; Polydoros, Fotis; Cacciatore, Silvia; Stenson, Laura; Kim, Dong-Wook

Efficacy and Safety of Asciminib in Heavily Pretreated Patients with Philadelphia Chromosome-Positive (Ph plus ) Chronic Myeloid Leukemia in Chronic Phase (CML-CP) with Sensitivity to Tyrosine Kinase Inhibitors (TKIs)

2020 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Hughes, Timothy; Mauro, Michael; Kim, Dong-Wook; Cortes, Jorge; Rea, Delphine; Minami, Hironobu; Breccia, Massimo; Deangelo, Daniel; Hochhaus, Andreas; Goh, Yeow-Tee; le Coutre, Philipp; Lang, Fabian; Cacciatore, Silvia; Aimone, Paola; Stenson, Laura; Polydoros, Fotis; Talpaz, Moshe

Combination of Asciminib plus Nilotinib or Asciminib plus Dasatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results

2019 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Deangelo, Daniel J.; Mauro, Michael J.; Kim, Dong-Wook; Cortes, Jorge; RÃ©a, Delphine; Hughes, Timothy P.; Minami, Hironobu; Breccia, Massimo; Talpaz, Moshe; Hochhaus, Andreas; Tee Goh, Yeow; Le Coutre, Philipp D.; Sondhi, Manu; Mishra, Kaushal; Hourcade-Potelleret, Florence; Vanasse, Gary; Aimone, Paola; Lang, Fabian

Efficacy and Safety of Asciminib, a Specific Allosteric BCR-ABL1 Inhibitor Targeting the Myristoyl-Binding Site, in Patients with Chronic Myeloid Leukemia (CML) Carrying the T315I Mutation

2019 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Deininger, Michael W.; RÃ©a, Delphine; Lang, Fabian; Kim, Dong-Wook; Cortes, Jorge E.; Hughes, Timothy P.; Minami, Hironobu; Breccia, Massimo; Deangelo, Daniel J.; Hochhaus, Andreas; Talpaz, Moshe; Tee Goh, Yeow; Le Coutre, Philipp D.; Etienne, Gabriel; Sondhi, Manu; Mishra, Kaushal; Aimone, Paola; Mauro, Michael J.

Combination of Asciminib, a Novel and Specific BCR-ABL1 Inhibitor, Plus Imatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results

2019 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Talpaz, Moshe; Cortes, Jorge; Lang, Fabian; Kim, Dong-Wook; RÃ©a, Delphine; Mauro, Michael J.; Minami, Hironobu; Breccia, Massimo; Deangelo, Daniel J.; Hochhaus, Andreas; Tee Goh, Yeow; Le Coutre, Philipp D.; Sondhi, Manu; Mishra, Kaushal; Hourcade-Potelleret, Florence; Vanasse, Gary; Aimone, Paola; Hughes, Timothy P.